TOWNSON SHARON (Chief Technology Officer) sold 8.1% of their position (6K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $139.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/7/2026ACC: 0001193125-26-297558
Officer· Chief Technology Officer
Since Jun 2021
-6K
Net shares
Net seller
$139.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
6K acquired · 12K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+6K
Price / share
$6.14
Trade value
$36.84K
% of position
8.8%
7/6/2026
67.84K→73.84K
Common Stock
Direct
Shares
−5.60K
Price / share
$23.25
Trade value
$130.20K
% of position
7.6%
7/6/2026
73.84K→68.25K
Common Stock
Direct
Shares
−400.00
Price / share
$24.13
Trade value
$9.65K
% of position
0.6%
7/6/2026
68.25K→67.84K
Total
Net shares
+0.00
Net value
-$103.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/6/2026 | M · Option Exercise | +6K | $6.14 | $36.84K | 8.8% | 67.84K | 73.84K |
| Common Stock Direct | 7/6/2026 | S · Sale | −5.60K | $23.25 | $130.20K | 7.6% | 73.84K | 68.25K |
| Common Stock Direct | 7/6/2026 | S · Sale | −400.00 | $24.13 | $9.65K | 0.6% | 68.25K | 67.84K |
| Total | +0.00 | -$103.01K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
6K shares
Shares
−6K
Strike price
6.14
Held after
197.29K
Exercisable
—
7/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock6K shares | 7/6/2026 | M · Option Exercise | −6K | 6.14 | — | 197.29K |